Genetic Technologies Limited (GENE)
0.7650
0.00 (0.00%)
Inactive · Last trade price on Nov 14, 2024
Genetic Technologies Revenue
In the fiscal year ending June 30, 2024, Genetic Technologies had annual revenue of 9.67M AUD, down -6.52%. Genetic Technologies had revenue of 4.80M in the half year ending June 30, 2024, a decrease of -16.72%.
Revenue (ttm)
9.67M AUD
Revenue Growth
-6.52%
P/S Ratio
n/a
Revenue / Employee
175,869 AUD
Employees
55
Market Cap
3.78M USD
Revenue Chart
* This company reports financials in AUD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 9.67M | -675.11K | -6.52% |
Jun 30, 2023 | 10.35M | 1.13M | 12.25% |
Jun 30, 2022 | 9.22M | 7.88M | 590.65% |
Jun 30, 2021 | 1.33M | 496.87K | 59.30% |
Jun 30, 2020 | 837.87K | 812.42K | 3,192.98% |
Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionGENE News
- 1 year ago - BioVie and Genetic Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Accesswire
- 1 year ago - Join Genetic Technology's Exclusive Live Investor Webinar and Q&A Session on October 2 - GlobeNewsWire
- 1 year ago - Genetic Technologies Invited to Join Prestigious “CancerIQ” Online Platform - Provides Access to 45 Healthcare Systems and 250 Clinics - GlobeNewsWire
- 1 year ago - Genetic Technologies Strategic Restructure Driving USA Sales Growth - GlobeNewsWire
- 1 year ago - Genetic Technologies Announces Appointment of Chief Financial Officer & Company Secretary - GlobeNewsWire
- 1 year ago - GeneType Identifies 79.5% of People Tested are at Risk of Serious Disease - GlobeNewsWire
- 1 year ago - Join Genetic Technologies' Exclusive Live Investor Webinar and Q&A Session on June 27 - GlobeNewsWire
- 1 year ago - Appendix 4C & Quarterly Business Update – March 2024 - GlobeNewsWire